dilactide has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changi, K; Epstein, MM; Felfel, RM; Grant, DM; Hoffmann, O; Kampleitner, C; Kluger, R; Scotchford, CA; Sottile, V | 1 |
| Bastos, JK; da Silva Ferreira, D; de Albuquerque, S; de Gaitani, CM; E Silva, ML; Esperandim, VR; Ferraudo, AS; Lira, AA; Marchetti, JM; Saraiva, J | 1 |
2 other study(ies) available for dilactide and Disease Models, Animal
| Article | Year |
|---|---|
Preclinical biological and physicochemical evaluation of two-photon engineered 3D biomimetic copolymer scaffolds for bone healing.
Topics: Animals; Biomimetic Materials; Caproates; Cells, Cultured; Dioxanes; Disease Models, Animal; Female; Fractures, Ununited; Lactones; Mice; Osteoblasts; Osteoclasts; Osteogenesis; Primary Cell Culture; Stereolithography; Tissue Engineering; Tissue Scaffolds; Wound Healing | 2020 |
(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.
Topics: 4-Butyrolactone; Animals; Antiprotozoal Agents; Benzodioxoles; Chagas Disease; Delayed-Action Preparations; Dioxanes; Dioxoles; Disease Models, Animal; Humans; Lactic Acid; Lignans; Mice; Microspheres; Parasitemia; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Trypanosoma cruzi | 2010 |